These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33085974)

  • 1. Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States.
    Navalkele P; Guzman M; Kirby A; Pinz H; Kemp J
    J Neuropathol Exp Neurol; 2020 Nov; 79(11):1250-1252. PubMed ID: 33085974
    [No Abstract]   [Full Text] [Related]  

  • 2. Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
    Smith MJ; Wallace AJ; Bennett C; Hasselblatt M; Elert-Dobkowska E; Evans LT; Hickey WF; van Hoff J; Bauer D; Lee A; Hevner RF; Beetz C; du Plessis D; Kilday JP; Newman WG; Evans DG
    J Pathol; 2014 Dec; 234(4):436-40. PubMed ID: 25143307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.
    Libert DM; Prayson RA
    Ann Diagn Pathol; 2020 Jun; 46():151516. PubMed ID: 32311644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCE1 mutations in pediatric clear cell meningioma: case report.
    Evans LT; Van Hoff J; Hickey WF; Smith MJ; Evans DG; Newman WG; Bauer DF
    J Neurosurg Pediatr; 2015 Sep; 16(3):296-300. PubMed ID: 26114992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCE1 mutation screening in classification of clear cell meningiomas.
    Smith MJ; Ahn S; Lee JI; Bulman M; Plessis DD; Suh YL
    Histopathology; 2017 Apr; 70(5):814-820. PubMed ID: 27891692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.
    Tauziede-Espariat A; Parfait B; Besnard A; Lacombe J; Pallud J; Tazi S; Puget S; Lot G; Terris B; Cohen J; Vidaud M; Figarella-Branger D; Monnien F; Polivka M; Adle-Biassette H; Varlet P
    Brain Pathol; 2018 Jul; 28(4):466-474. PubMed ID: 28474749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on the article "Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri" by van den Munckhof et al.
    Prescott TE; Smith MJ; Evans DG
    Neurogenetics; 2012 Feb; 13(1):103-4. PubMed ID: 22203059
    [No Abstract]   [Full Text] [Related]  

  • 8. SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome.
    Fiorentini E; Giunti L; Di Rita A; Peraio S; Fonte C; Caporalini C; Buccoliero AM; Censullo ML; Gori G; Noris A; Pasquariello R; Battini R; Pavone R; Giordano F; Giglio S; Rinaldi B
    Eur J Med Genet; 2023 Jul; 66(7):104784. PubMed ID: 37164167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.
    Raffalli-Ebezant H; Rutherford SA; Stivaros S; Kelsey A; Smith M; Evans DG; Kilday JP
    Childs Nerv Syst; 2015 Mar; 31(3):441-7. PubMed ID: 25249420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1 mutations are not a common cause of multiple meningiomas.
    Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
    J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of genetic counseling and screening for people with pathogenic SMARCE1 variants: A family study.
    Shoakazemi A; Hewitt A; Smith MJ; du Plessis D; Thomas O; Stivaros SM; Deniz K; Hammerbeck-Ward C; Rutherford SA; King AT; Evans DG
    Am J Med Genet A; 2021 Feb; 185(2):561-565. PubMed ID: 33185983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
    Smith MJ; O'Sullivan J; Bhaskar SS; Hadfield KD; Poke G; Caird J; Sharif S; Eccles D; Fitzpatrick D; Rawluk D; du Plessis D; Newman WG; Evans DG
    Nat Genet; 2013 Mar; 45(3):295-8. PubMed ID: 23377182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening.
    Gerkes EH; Fock JM; den Dunnen WF; van Belzen MJ; van der Lans CA; Hoving EW; Fakkert IE; Smith MJ; Evans DG; Olderode-Berends MJ
    Neurogenetics; 2016 Apr; 17(2):83-9. PubMed ID: 26803492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
    Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
    Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline and somatic mutations in meningiomas.
    Smith MJ
    Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
    Sievers P; Sill M; Blume C; Tauziede-Espariat A; Schrimpf D; Stichel D; Reuss DE; Dogan H; Hartmann C; Mawrin C; Hasselblatt M; Stummer W; Schick U; Hench J; Frank S; Ketter R; Schweizer L; Schittenhelm J; Puget S; Brandner S; Jaunmuktane Z; Küsters B; Abdullaev Z; Pekmezci M; Snuderl M; Ratliff M; Herold-Mende C; Unterberg A; Aldape K; Ellison DW; Wesseling P; Reifenberger G; Wick W; Perry A; Varlet P; Pfister SM; Jones DTW; von Deimling A; Sahm F;
    Acta Neuropathol; 2021 Feb; 141(2):281-290. PubMed ID: 33319313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary clear cell meningiomas in a single family: three-cases report.
    Inoue T; Shitara S; Ozeki M; Nozawa A; Fukao T; Fukushima T
    Acta Neurochir (Wien); 2018 Dec; 160(12):2321-2325. PubMed ID: 30421029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningioma: A Pathology Perspective.
    Toland A; Huntoon K; Dahiya SM
    Neurosurgery; 2021 Jun; 89(1):11-21. PubMed ID: 33588439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade meningiomas: biology and implications.
    Bi WL; Prabhu VC; Dunn IF
    Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
    Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
    Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.